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Abstract
Background: Few data are available on the prevalence of cognitive impairment (CI) in Spain, and the existing
information shows important variations depending on the geographical setting and the methodology employed.
The aim of this study was to determine the prevalence of CI in individuals aged over 65 in an urban area, and to
analyze its associated risk factors.
Methods: Design: A descriptive, cross-sectional, home questionnaire-based study; Setting: Populational, urban
setting. Participants: The reference population comprised over-65s living in the city of Salamanca (Spain) in 2009.
Randomized sampling stratified according to health district was carried out, and a total of 480 people were
selected. In all, 327 patients were interviewed (68.10%), with a mean age of 76.35 years (SD: 7.33). Women
accounted for 64.5% of the total. Measurements: A home health questionnaire was used to obtain the following
data: age, sex, educational level, family structure, morbidity and functionality. All participants completed a
neuropsychological test battery. The prevalence data were compared with those of the European population, with
direct adjustment for age and sex. Diagnoses were divided into three general categories: normal cognitive
function, cognitive impairment - no dementia (CIND), and dementia.
Results: The prevalence of CI among these over-65s was 19% (14.7% CIND and 4.3% dementia). The age-and sex-
adjusted global prevalence of CI was 14.9%. CI increased with age (p < 0.001) and decreased with increasing
educational level (p < 0.001). Significant risk factors were found with the multivariate analyses: age (OR = 1.08, 95%
CI: 1.03-1.12), anxiety-depression (OR = 3.47, 95%CI: 1.61-7.51) and diabetes (OR = 2.07, 95%CI: 1.02-4.18). In turn,
years of education was found to be a protective factor (OR = 0.79, 95%CI: 0.70-0.90). Although CI was more
frequent among women and in people living without a partner, these characteristics were not significantly
associated with CI risk.
Conclusions: The observed raw prevalence of CI was 19% (14.9% after adjusting for age and sex). Older age and
the presence of diabetes and anxiety-depression increased the risk of CI, while higher educational level reduced
the risk.
Background
The prevalence of neurodegenerative diseases increases
with age [1,2]. Considering that the Spanish population
is among the oldest in the world (particularly the
Autonomous Region of Castilla y León, where 22.5% of
the inhabitants are aged over 65) [3], a substantial
increase in the prevalence of cognitive impairment (CI)
is to be expected in the coming years.
It is difficult to estimate prevalence figures for CI,
since the diagnostic criteria are imprecise [4,5]. Indeed,
the published dementia prevalence data for both
Spain [2,6-8] and other European countries [1,9,10]
show great variation. Therefore, it is not possible at pre-
sent to provide reliable figures applicable to our setting.
Although direct age-adjusted comparisons have been
made among the different study populations, there are
other influencing variables with greater adjustment pro-
blems, such as the setting (rural-urban), living in the
home or in institutions, the diagnostic criteria used [11],
or educational level. Also, more recent attempts to
* Correspondence: emilianorodriguezsanchez@yahoo.es
1Primary care research unit of La Alamedilla Health Center, Castilla y León
Health Service- SACYL, Salamanca, Spain
Full list of author information is available at the end of the article
Rodríguez-Sánchez et al. BMC Neurology 2011, 11:147
http://www.biomedcentral.com/1471-2377/11/147
© 2011 Rodríguez-Sánchez et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.reformulate the constructs propose a clinical spectrum
of CI ranging from mild cognitive impairment through
dementia and a corresponding physio-pathological sub-
strate believed to be responsible for the clinical symp-
toms [4,5]. The analysis of interventions that may prove
effective in preventing the problems associated with CI
is generating much interest, since the established thera-
pies applied to CI are scarcely effective. However, the
data available on the prevalence of CI in Spain are even
more limited than in the case of dementia, and show
important variations depending on the geographical set-
ting and the methodology employed.
The present study carry out to estimate the prevalence
of CI in the urban population over 65 years of age in
the city of Salamanca (Spain), and to describe the fac-
tors associated with CI.
Methods
Study design
An observational, descriptive, cross-sectional population
study.
Setting
The reference population was that of the city of Sala-
manca, with 172,375 inhabitants, of which 19.74%
(34,020) were aged over 65. It includes 10 healthcare
areas, each with a population of between 9,000 and
26,000 inhabitants.
Participants
We selected all those aged over 65 on 1 January 2009
and living in the city of Salamanca (urban setting). A
door-to-door population-based survey was carried out
during the months of May to November 2009. Two
weeks before the interviews, letters were sent to the
selected individuals, explaining the purpose of the study
and requesting their cooperation. Confidentiality of data
was guaranteed. Ten days after sending the letters, a tel-
ephone call was made to arrange a home interview.
The following exclusion criteria were applied
1) deceased individuals; 2) errors in address: a) when the
letter was returned, or when the selected person or
some reliable informer could not be located after 4 visits
to the home or 4 telephone calls on different dates and
at different times; b) persons who had moved out of the
study area; and 3) those individuals who declined to par-
ticipate in the study.
Ethical aspects
The protocol was approved by the Research Ethics Com-
mittee of Salamanca University Hospital. Participants
signed the consent document after receiving the first
explanatory letter providing information on the study.
Training of the evaluators
The principal researcher coordinated the entire process.
The evaluators were four psychologists trained by one
of the researchers (SMS) to carry out the interview with
the programmed questionnaires. A manual was drafted,
describing the appointment procedure and application
of the interviews, and was reviewed with the inter-
viewers over two sessions. We also used two recorded
home interviews in the training sessions. During the
study, communication was permanently maintained for
resolving any doubts or dealing with incidents in rela-
tion to the questionnaires.
Data sources
The sample was taken from the Castilla y León Regional
Health Service lists, which cover 99.5% of the popula-
tion. The lists included both community dwellers and
institutionalized elders.
Study size
A c c e p t i n ga na l p h ar i s ko f0 . 0 5a n dab e t ar i s ko f0 . 2 0 ,
estimating a CI prevalence of about 16% [12], with an
error of 4%, and considering the current population
aged over 65, a total of 320 patients was required.
A s s u m i n gal o s sr a t eo fu pt o5 0 %d u et on o n -
responses, as observed in similar studies, the calculated
sample size was 480 individuals. In the secondary analy-
sis of cases and controls, with a 327 participants sample,
the statistical power was of 79.4% to detect an Odds
Ratio of 2.5 with a confidence level of 95% (Epidat 4.0).
We carried out a stratified random sampling by health
districts. In order to reach the required sample size, we
made a replacement for lost participants. The sample
size of each health district was proportional to its popu-
lation over 65 years. In a first stage, 260 interviews were
carried out, accounting for 80% of the required sample.
Two months later, in a second stage, we replaced the
losses within each health district and 67 more people
were interviewed. The most common cause of losses
was patient refusal to participate (83.0%). This was par-
ticularly the case among the younger individuals (mean
age: 75.94 ± 7.01 years) (p < 0.001). In turn, 12 patients
were excluded because they had moved out of the study
d i s t r i c t( 7 . 8 % ) ,w h i l e1 4h a dd i e d( 9 . 2 % )( F i g u r e1 ) .
There were no significant differences between sexes
regarding the cause of losses, or between losses in the
first and second recruitment stages. Non-responders
represented 34.83% of the males and 30.13% of the
females. The distribution by age groups is shown in
Table 1. Mean age of the males was 76.61 years (SD: ±
7.65), versus 77.52 years (SD: ± 7.92) in the females.
There were no differences in distribution between the
different sex and age categories. A total of 327 partici-
pants were interviewed, representing 68.1% of those
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211 were women (64.5%), with a mean age of 76.35
years (SD:± 7.33) similar in the two sexes.
Measurements
A health questionnaire was administered (OARS Multi-
dimensional Functional Assessment Questionnaire) [13]
in the participant’s home, for obtaining data on sociode-
mographics (age, sex, marital status), years of education,
basic and instrumental activities of daily living, personal
situation (people living with the patient, number of liv-
ing offspring), morbidity (Charlson comorbidity index
[14]), drug use and neuropsychological aspects. Marital
status was classified according to whether the person
was living with or without a partner (widowed, single,
separated), while educational level was classified as fol-
lows: illiterate (failure to complete basic education), pri-
mary-secondary education (4-9 years of education) and
higher education (over 9 years). Regular professional
occupation before retirement was defined as domestic
chores, full-time job, others (part-time job, long-term
unemployment, etc.). The Katz Index of Independence
in Activities of Daily Living (Katz ADL) was applied to
assess functional status as a measure of patient ability to
perform activities of daily living (ADLs) independently
[15]. This test provides information on dependence or
independence, not only in terms of the number of areas,
but also identifying the specific areas. The information
obtained is of a qualitative and descriptive nature, and
does not provide a total score on the person’s functional
state.
At the beginning of the interview, neuropsychological
assessment of patient cognitive status was carried out
using a brief neuropsychological test battery including
the following: Mini-Mental State Examination
(MMSE) [16] in its validated Spanish version [17] to
evaluate general cognitive state, with the possibility of
assessing cognitive functions separately; the 7 Minute
Figure 1 Flow chart of the DERIVA Study.
Table 1 Distribution according to gender and different age ranks of interviewed and lost sample population.
Female (N = 302) Male (N = 178) Total (N = 480)
Age (years) Interviewed Lost Interviewed Lost Interviewed Lost
Mean (SD) 76.64 (7.64) 77.52(7.08) 75.81 (6.73) 76.61 (7.65) 76.35 (7.33) 77.15 (7.80)
65-69 (%) 21.3 17.6 20.74 19.4 21.1 18.3
70-74 (%) 21.8 20.9 22.4 25.8 22.0 22.9
75-79 (%) 20.4 25.3 27.6 21.0 22.9 23.5
80-84 (%) 19.5 17.6 19.0 14.5 19.3 16.3
≥ 85 (%) 17.1 17.1 10.3 19.3 14.7 19.0
Total: N (%) 211 (64.5%) 91 (59.5%) 116 (35.5%) 62 (40.5%) 327 (100%) 153 (100%)
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evaluate general cognitive state, as well as temporal
orientation, memory, constructive praxias and language,
separately; the Benton temporal orientation test [20] to
evaluate temporal orientation; the Enhanced cued recall
test [21] to evaluate episodic memory; the Clock draw-
ing test [22] to evaluate constructive praxias; and the
Categorical fluency task [23] to evaluate language. The
cut-off points for cognitive impairment established for
each test are as follows: MMSE<24; 7MS≤ percentile 20;
Benton temporal orientation test ≤ 102; Enhanced cued
recall test ≤ 12; Clock drawing test <3; Verbal fluency ≤
10.
During the structured interview, participants were
asked to present whatever relevant clinical records they
might have, together with details of their current medi-
cations. In the 16 patients who were unable to complete
the neuropsychological evaluation because of a deterio-
rated clinical condition - heart failure (2 cases), deafness
(4 cases), severely impaired vision (2 cases) or severe
mental impairment (4 cases) - the clinical and objective
data were collected from the presented documentation,
or by interviewing the caregiver or informant who knew
the individual. We considered as reliable informants, in
order of preference, a family member living in the same
house as the individual (spouse, son/daughter, sibling); a
person responsible for the care of the individual; some-
one living in the same house but not a family member;
or a relative of the person not living in the same house.
At the end of the interview the interviewers drafted a
report on the quality of the information collected and
on the social and health conditions of the person inter-
viewed. Seventeen participants lived in homes for the
elderly (5.2%). All the information was evaluated by the
researchers (ERS, SMS, RGG and MVP) with a view to
establishing the final diagnosis. The diagnoses were
divided into three general categories: normal cognitive
function, cognitive impairment - no dementia (CIND),
and dementia.
Classified as cognitive impairment - no dementia (CIND)
CIND was defined as: 1) mild cognitive or functional
impairment reported by the participant or informant
that did not meet criteria for dementia; or 2) perfor-
mance on neuropsychological or functional measures
that was both below expectations and ≥ 0.5 standard
deviations below published norms on any test [24].
Classified as dementia
A diagnosis of dementia was made based on the Diag-
nostic and Statistical Manual of Mental Disorders (IV
Edition) criteria: the participant must present the devel-
opment of multiple cognitive deficits including memory
impairment and impairment in at least one other
cognitive domain representing a decline from the pre-
vious level of functioning and of sufficient severity to
cause impairment in function [4,5]. At a functional
level, the person must present dependence in at least
t w of u n c t i o n a la r e a s ,l e a d i n gt oi n t e r f e r e n c ei nb a s i c
activities of daily living. Alterations at both the cognitive
and functional levels were indicated by low performance
and scores below the cut-off points in the neuropsycho-
logical and functional tests. As regards functional state,
the person must present a minimum level of alteration
in at least two functional areas. All of this must be
accompanied by concern on the part of the participants
about a change at a cognitive level compared to his or
her previous state [4,5,25].
Statistical analyses
The raw prevalence of CIND and dementia were calcu-
lated taking into account the total cases of CIND and
dementia with respect to the total study sample. We
estimated both global prevalence and specific prevalence
per age group, sex, educational level, morbidity and
functionality. Calculation was made of the 95% confi-
d e n c ei n t e r v a l s( 9 5 % C I )f o rt h eg l o b a la n ds p e c i f i cp r e -
valence, together with prevalence adjusted for age and
sex, using the European standard population [26] as a
basis for adjustment (weighting: 36.4, 27.3, 18.2, 9.1 and
9.1 for age intervals of 65-69, 70-74, 75-79, 80-84 and =
85 years, respectively).
The continuous variables were expressed as the mean
± standard deviation (SD), while frequency distributions
were used for the qualitative variables. Logistic regres-
sion analysis was used to explore the sociodemographic,
functional and clinical factors independently associated
with the presence of CIND/dementia. The enter method
was used in a first step to include the adjusting variable
(patient age and sex), followed in a second step by the
stepwise method in application to the rest of the inde-
pendent variables: years of education, educational level,
Katz index, living with partner, restlessness, anxiety or
depression, sleeping problems or insomnia, diabetes and
Charlson comorbidity index. The dependent variable
was cognitive impairment (CI)(code 0: no CI; code 1:
presence of CI), while in the case of the independent
variables the reference groups were male sex, illiteracy,
absence of diabetes, no insomnia, no depression, and liv-
ing without a partner. Patient age, the Katz index, years
of education and the Charlson comorbidity index were
taken as continuous variables. The data were analyzed
using the SPSS/PC+ version 18.0 statistical package
(SPSS Inc., Chicago, IL, USA).
Results
Table 2 shows the raw, age-adjusted and age-and sex-
adjusted prevalence of CIND (48 participants, 14.7%)
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Page 4 of 13and dementia (14 participants, 4.3%). In total, 62 of the
327 participants studied (19.0%) suffered from CI
(CIND or dementia). On standardizing for age, the pre-
valence decreased similarly in men and women - the
estimated adjusted prevalence being 16.1% (95%CI: 11.6-
20.6), versus 14.9% when adjusted for age and sex. The
prevalence of CIND and dementia increased with age (p
< 0.001), and women were seen to predominate among
the individuals with CIND (79.16%) and in those with
dementia (71.42%) (Figure 2). The 14 patients classified
as presenting dementia had a mean age of 79.35 years
(SD = 7.33), and in 8 cases (57.14%) the cause
corresponded to Alzheimer’s disease (AD), in 3 cases
(21.43%) to probable vascular disorders, and in 3 cases
(21.43%) to a mixture of factors.
Table 3 shows the characteristics of the 327 DERIVA
study participants, stratified by cognitive status. Mean
age was lower in the normal cognition group, while edu-
cational level was higher. The patients with CI had
lower Charlson comorbidity scores. Figure 3 shows the
prevalence of CIND according to educational level and
the functional clinical and neuropsychological character-
istics of the participants. The prevalence of CI among
the illiterate participants was 34%, versus 25.5% among
Table 2 Crude, age-adjusted, and age- and sex-adjusted prevalence of dementia and cognitive impairment (CI).
Crude Age-adjusted
a Age, sex ajusted
a No. individuals
b
PP PE 95 CI PP 95 CI PP 95 CI Count 95 CI
CI (Dementia+ CIND)
Male 14/116 12,1 6,1 18,0 10,7 4,6-16,9
Female 48/211 22,7 17,1-28,4 19,1 12,9-25,2
Both 62/327 19,0 14,7-23,2 16,1 11,6-20,6 14,9 10,6-19,2 51 36-65
Age-group
65-69 9/69 13,0 5,1-21,0
70-74 8/72 11,1 3,9-18,4
75-79 9/75 12,0 4,6-19,4
80-84 15/63 23,8 13,3-34,3
≥ 85 21/48 43,8 29,7-57,8
CIND
Male 10/116 8,6 3,5 - 13,7 8,1 2,5-13,6
Female 38/211 18,0 12,8 - 23,2 15,1 9,6-20,6
Both 48/327 14,7 10,8 - 18,5 11,4 7,5-15,4 11,6 7,7-15,5 39 26-53
Age-group
65-69 8/69 11,6 4,0-19,1
70-74 7/72 9,7 2,9-16,6
75-79 3/75 4,0 0,0-8,4
80-84 12/63 19,0 9,4-28,7
≥ 85 11/48 22,9 11,0-34,8
Dementia
Male 4/116 3,4 0,1 - 6,8 2,7 0,0 - 5,3
Female 10/211 4,7 1,9 - 7,6 4,0 1,3 - 6,8
Both 14/327 4,3 2,1 - 6,5 3,4 1,5 - 5,3 3,3 1,4 - 5,2 11 5-18
Age-group
65-69 1/69 1,4 0,0 - 4,3
70-74 1/72 1,4 0,0 - 4,1
75-79 6/75 8,0 1,9 - 14,1
80-84 3/63 4,8 0,0 - 10,0
≥ 85 3/48 6,3 0,0 - 13,1
aAge standardization weights European Standard: 36.4, 27.3, 18.2, 9.1 and 9.1 for 65-69, 70-74, 75-79, 80-84 and ≥85, respectively; sex standardization weight:
0.50 (sources: http://www.wmpho.org.uk/localprofiles/metadata.aspx?id=META_EUROSTD) [26];
bEstimated number of subjects in hundreds with de disease based on age- and sex-adjusted prevalence (Salamanca h ≥65 years 2009 estimated population:
34.020h. (source: Castilla and León Regional Health Service lists. CIND: cognitive impairment not dementia; CI, confidence interval; PE, prevalence point-estimate;
PP, crude prevalence ratio (cases divided by population).
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Page 5 of 13the patients living without a partner. The prevalence of
CI among the individuals with depression, insomnia,
hypercholesterolemia or diabetes was over 27%. In turn,
10.4% of the participants who were independent for
their activities of daily living (ADLs) as assessed with
the Katz index suffered from CI, versus 26.9% of the
participants found to be dependent for two or more
ADLs.
Significant predictor factors were found with the mul-
tivariate analyses: age (OR = 1.08, 95%CI: 1.03-1.12),
anxiety-depression (OR = 3.47, 95%CI: 1.61-7.51), dia-
betes (OR = 2.07, 95%CI: 1.02-4.18) and educational
level (OR = 0.79, 95%CI: 0.70-0.90) (Table 4).
Discussion
The observed prevalence of 14.7% for CIND and 4.3%
for dementia implies a total of 19% of all people aged
over 65 with CI in the city of Salamanca in 2009. The
age-adjusted and age-and sex-adjusted overall prevalence
(CIND or dementia) was 14.9% (95%CI: 10.6-19.2). The
prevalence of CI increased with age and decreased with
increasing educational level. Although CI was more fre-
quent among women and in people living without a
partner, these characteristics were not significantly asso-
ciated with CI risk. Significant risk factors were found
with the multivariate analyses: age, anxiety-depression
and diabetes, while years of education proved to be a
protective factor.
Few population-based studies of CI have been pub-
lished in Spain. Adequate comparisons are therefore diffi-
cult to make, though our data are within the lower range
of other Spanish studies (13.8-35.2%) [27-31] and Eur-
opean surveys [1,10,32]. A possible explanation for this
relatively low prevalence may be the fact that our study
was conducted in an urban setting. Large differences
have been found among different Spanish regions. In this
regard, Murcia yielded a CIND prevalence of 13.8% in
the urban setting, versus 23.3% in the rural zone [27].
Nunes et al. [10], in an urban setting in the north of Por-
tugal, reported a lower prevalence of CI (12.0%), though
these authors included a younger age group (55 to 79
years). The raw prevalence of CI found in our study is
lower than the 22.2% reported for the United States
[24,33] or the 16.8% prevalence of CIND and 8% preva-
lence of dementia estimated for Canada [12].
In our study we took into account the most up-to-
date diagnostic criteria [4,5,24] according to which it is
considered that CIND can involve alteration in various
higher cognitive functions, and not only in memory.
Therefore, we should have obtained higher figures than
if we had considered the criteria of Petersen et al [34].
On the other hand, however, the Katz ADL Index is less
sensitive for assessing ADLs than for assessing more
complex activities.
The literature offers more references to the prevalence
of dementia, though consensus in this case is likewise
Figure 2 Crude, age-adjusted and age- and sex-adjusted prevalence of CIND and dementia.
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Number of subjects = 327 265(81.0) 62 (19.0)
Age
# 75.46 ± 6.83 80.15 ± 8.18 <0.001
Male 75.26 ± 6.52 80.00 ± 7.22 0.013
Female 75.58 ± 7.04 80.19 ± 8.50 <0.001
Sex, n (%) 0.018
Male 102 (87.90) 14 (12.1)
Female 163 (77.30) 48 (22.7)
Years of education
# 8.77 ± 2.77 6.93 ± 2.81 <0.001
Educational level, n (%) <0.001
Iliterate 68 (66.0) 35 (34.00)
Primariy-Secondary education 152 (87.90) 21 (12.1)
Higher education 45 (91.8) 4 (8.2)
Regular occupation in his/her life, n (%) 0.137
Housewife 68 (74.70) 23 (25.30)
Full-time job 174 (84.10) 33 (15.90)
Others 8 (88.90) 1 (11.1)
Living with his/her partner, n (%) 158 (86.30) 25 (13.7) 0.007
Number of alive children (Mean ± SD) 2.41 ± 1.87 2.09 ± 1.99 0.265
Living with someone, n (%) 0.065
Alone 56 (90.30) 6 (9.70)
With one relative/friend 149 (81.0) 35 (19.00)
With at least with 2 people 47 (75.80) 15 (24.20)
With more than 2 people 4 (57.10) 3 (42.90)
Functionals
Activities of daily living (Katz Index): <0.001
All preserved 120 (45.30) 14 (22.60)
Needs help on one activity 49 (18.10) 10 (16.10)
Needs help on bathing and other activity 1 (0.40) 1 (1.60)
Needs help on 6 activities 0 (0.00) 2 (3.20)
Needs help on at least 2 activities, but not classifiable on previous categories 95 (35.80) 35 (56.50)
Clinicals
Depression 30 (11.30) 17 (27.40) 0.001
Insomnia 41 (15.50) 17 (27.40) 0.027
Taking medicine for depression 28 (10.6) 17 (27.40) 0.001
Taking medicine for insomnia 38 (14.30) 15 (24.20) 0.058
Hypertension 119 (45.20) 22 (35.50) 0.163
Dyslipidemia 12 (4.50) 5 (8.10) 0.259
Diabetes Mellitus 47 (17.70) 18 (29.90) 0.045
Charlson comorbidity Index (by age) 3.90 ± 1.46 4.50 ± 1.23 0.004
Neuropsychologicals
MMSE (0-30)
# 27.30 ± 2.05 19.12 ± 4.74 <0.001
MMSE <0.001
0-13 0 (0.00) 5 (8.10)
14-23 3 (1.10) 43 (69.40)
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Nevertheless, it has been suggested that the prevalence
in this country is lower than in other regions of Europe.
Our data point to an adjusted dementia prevalence in
the city of Salamanca of 3.3%, which is close to the low-
est estimates both in Spain [2,6] and in Europe [32].
Crude dementia prevalence for elders aged 70 years and
over range from 5% in Murcia [27] to 17.2% in Pam-
plona [2].
Recent publications suggest that the number of indivi-
duals with CIND in the United States is about 70% higher
than the number with dementia. In the 71- to 79-year-old
age group, 16% had CIND, whereas an additional 5% had
dementia. A similar proportion was found in the recent
Mexican Health and Aging Study [35], though the preva-
lence figures are slightly higher: 6.1% for CIND as against
28.7% for dementia. Another possible reason why these
differences cannot be explained is the threshold set, since,
as Seshadri et al. [36] pointed out, depending on where
the differential threshold is placed, the percentages of
CIND and dementia will vary. It should also be borne in
mind that when a report is requested from an informant
about the person’s functional limitations, the prevalence is
substantially lower [2,6,11]
It must be taken into account that the study was
designed to determine the global prevalence of CI, and
that the estimation of dementia prevalence would
require a larger sample. These results therefore must be
viewed with caution. The study was carried out in a ran-
dom sample of the population of the city that included
people living in homes for the elderly, and since the pre-
valence of dementia in these institutions is higher than
in the community [12] the possible associated bias has
been avoided. However, the percentage distribution
according to the most likely etiology coincides with the
data of most other reports - Alzheimer’s disease
accounting for over one-half of the cases, followed by
vascular dementia.
At present, evaluation of the existing data is the sub-
ject of even greater debate than the publication of new
data [2,24,34,35,37]. It has been reported that the esti-
mates of probable dementia are higher in surveys than
in meta-analyses for the 65-84 year age interval, but
similar among individuals aged 85 years and older [38].
In our study we obtained sufficient information in the
context of a health survey, including evaluations of
patient functionality and clinical and neuropsychological
conditions, to determine the cognitive status of each
participant [13]. Such information is therefore more
relevant than that derived only from the application of a
battery of tests. The diagnostic criteria employed are
similar to those used in recent epidemiological stu-
dies [33,36] with the purpose of obtaining results that
can be compared with those collected in other settings,
and also of examining the tendencies in disease preva-
lence in a single district in relation to morbidity among
the elderly, healthcare, social support and economic
resources. In accordance with the current recommenda-
tions for conducting epidemiological studies, on includ-
ing patients with cognitive impairment, we placed
priority on the inclusion of all individuals who possibly
presented such impairment - since it was not our main
objective to analyze the types or the severity of demen-
tia. In other words, we placed greater emphasis on the
use of those evaluating instruments affording greater
sensitivity, at the cost of lesser specificity. Those surveys
based only on the detection of dementia can underesti-
mate the true incidence of neurodegenerative diseases in
their milder stages. Considering all of the above, it is
even more striking that the CI prevalences found are
among the lowest published to date. There is no con-
sensus regarding which functionality scales and neurop-
sychological batteries [39] are best suited to use in
epidemiological studies in dementia, despite the fact
that both elements have classically been used in diag-
nosing the disease [34]. It is exceptional for prevalence
studies to specify how functionality has been evaluated
[8], though we agree with Thomas et al. [40], who
recommended the incorporation of functional disability
data as a complement to studies estimating the
Table 3 Sociodemographic, functional, clinical and neuropsychological characteristics of the participants according to
cognitive impairment (CI). (Continued)
24-28 162 (61.10) 3 (4.80)
>28 81 (30.60) 0 (0.00)
Benton temporal orientation test 5.16 ± 15.96 38.00 ± 35.66 <0.001
Clock drawing test# 5.97 ± 1.52 3.91 ± 2.35 <0.001
Category Fluency# 15.90 ± 5.04 9.45 ± 4.75 <0.001
7 Minute Screen (Total)# 48.82 ± 14.48 67.38 ± 31.87 <0.001
CI: cognitive impairment (CIND or dementia); MMSE: Minimental State Examination.
#: Mean ± Standard deviation
p: Statistically significant differences between the two groups
MMSE: Mini-Mental State Examination score.
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Page 8 of 13prevalence and severity of CI in the community. In our
study, functionality was evaluated with the Katz ADL
index, which is widely used to evaluate elderly people in
an objective manner, and is therefore adequate for
establishing comparisons among different populations.
Among the participants of the DERIVA study, only
45.30% of those classified as not presenting CI, versus
22.60% of those classified as presenting CI, preserved
functionality in all the areas evaluated by the Katz ADL
index. Disability is common among people over 65 years
of age; as a result, the way in which disability is evalu-
ated exerts a strong influence when it is considered in
the diagnosis of CI. Both the Lawton PSMS-IADL and
the Katz scales remain widely used in psychosocial inter-
vention research, and are easy to complete. The PSMS-
IADL is not as popular as the Katz index, but has an
option for patient self-report. The Katz and PSMS-IADL
have been used widely in anti-dementia drug studies
Figure 3 Prevalence of CIND, CI or dementia according to level of studies, the features functional, clinical and neuropsychological
participants.
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Page 9 of 13and in some psychosocial intervention studies in both
North America and Europe [41,42]. Although the classi-
cal criteria of mild cognitive impairment (MCI) [34]
excluded the presence of important functional deficits,
the need to revise this approach has recently been sug-
gested [43]- particularly when distinguishing between
dementia and CIND, where different types of impair-
ment are included [44]. Difficulties remembering
appointments, telephone numbers, family meetings, holi-
days, medicines or domestic economics, or running
businesses or filling out certain documents, can all be
useful for suspecting early-stage CI [45]. Although less
extensively studied, it is also necessary to consider sta-
tistical analyses of the results obtained with the different
tests, taking into account that patient problems in
obtaining better scores are not always attributable to CI.
As an example, it has been described that 11 of the 30
items of the MMSE show high variability due to aspects
unrelated to the degree of CI. Therefore, the MMSE
would not be recommended as an instrument for use in
screening for dementia among patients with Parkinson’s
disease [46].
The importance of certain personal factors
Our data coincide with those of practically all studies
regarding the increase in CI with advancing age (Figure
2). It has been estimated that between 65 and 85 years
of age, the prevalence doubles every 5.2 years, in an
exponential manner [47]. However, there is no general
agreement regarding prevalence in terms of patient sex.
The condition is rarely associated with the male sex
[48], while in contrast many studies have associated
dementia with the female sex [2,29,31,49,50], since
women predominate in descriptive studies, and a corre-
lation is found in the bivariate analyses, in accordance
with our own observations. However, on considering
other variables such as age, educational level or comor-
bidity, this relationship disappears. Our data would sup-
port the idea that dementia is not associated with
women [1,25,27,33,47]. In coincidence with our own
study, many authors [7,33,51] have described an inverse
relationship between the prevalence of CI and a lower
educational level. Thus, it has been suggested that these
differences could be related to certain biological
mechanisms that would be responsible for this associa-
tion [8,27,29,52,53]. However, a recent epidemiological
study based on 875 necropsies revealed no protective
effect of the years of education received in early stages
in life in relation to the accumulation of neurodegenera-
tive or vascular pathologies of the brain [54]. Even so, it
has been suggested that when the disease affects people
with higher educational level, the manifestations are
milder, being mitigated by a greater coping capacity -
thereby postponing their consequences for a period of
time. It remains to be clarified whether educational
levels developed in later periods in life may or may not
affect the development of dementia. In an attempt to
offer information on this issue, we analyzed the type of
regular professional activity of the DERIVA study
patients before retirement, though no relationships were
found. Perhaps a different classification of activity, ana-
l y z i n gt h o s ew h i c hm a yc o n t r i b u t em o s tt oi n t e l l e c t u a l
development, could help identify a relationship. Regard-
ing the family situation, we found that those participants
living with their partner showed a 13.7% lower preva-
lence of CI than those living without a partner (p =
0.007). This is in agreement with the observations of
Helmer [55], who found single individuals to have a
greater risk of suffering dementia than married people.
In our case there were no differences related to the fact
of living alone or with one or more people, in terms of
t h ep r e v a l e n c eo fC I .A so u r si sac r o s s - s e c t i o n a ls t u d y ,
however, neither of these characteristics offers informa-
tion for clarifying whether the current situation is a con-
sequence of or a risk factor for the development of CI.
Many chronic illnesses can be found in elderly people.
The Charlson score was greater among the individuals
with CI (p = 0.004), though the multivariate analysis did
not find it to behave as a risk factor for CI. The associa-
tion between diabetes (p = 0.045) and dementia has
already been described in classic studies [52], though it
must be mentioned that while arterial hypertension is
accepted as being more closely associated with stroke
[31,51], diabetes is the disease found to be associated
with CI in the logistic regression analyses. The associa-
tion between CI and diabetes, as well as the absence of
an association with arterial hypertension and hypercho-
lesterolemia, coincide with the findings in another Span-
ish region [56]. It appears that brain damage would be
r e l a t e dt ov a s c u l a rm e c h a n i s m s[ 3 3 , 3 7 ] ,a n ds i n c et h e
prevalence of these cardiovascular diseases is not homo-
geneous in all regions, they should be considered in CI
prevalence studies with a view to establishing compari-
sons. People with CI more often have sleeping problems
(p = 0.027) and anxiety-depression (p < 0.001), though
only the latter was seen to behave as a CI risk factor in
the multivariate analysis. In coincidence with Johansson
Table 4 Variables associated with presenting cognitive
impairment (CI): OR and 95 confidence intervals for total
CIND/dementia vs. Controls/Healthy.
B OR (95% CI) P
Age 0.07 1.08 (1.03-1.12) 0.00
Gender 0.58 1.79 (0.88-3.64) 0.11
Years of education -0.24 0.79 (0.70-0.90) 0.00
Depression-anxiety 1.25 3.47 (1.61-7.51) 0.00
Diabetes 0.73 2.07 (1.02-4.18) 0.04
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Page 10 of 13et al. [57], we found an association between psychologi-
cal stress and CI, though in the study by the mentioned
authors this association was detected in middle-aged
women.
Among the limitations of our study, mention must be
made of the lack of consensus on the precise criteria
involved in making comparisons between different epi-
demiological studies. Another common and important
limitation in studies of this kind is the possible loss of
the more seriously deteriorated individuals, since it has
been shown that those people who refuse to participate
are more likely to have more seriously impaired cogni-
tive function [58] - a situation which may introduce bias
and alter the prevalence data obtained. A further limita-
tion of the study is that since the evaluations were car-
ried out by four different psychologists, inter-observer
reliability may be affected. However, each evaluation
was followed by an appraisal of the interview with a
view to tests correction and the reduction of possible
bias. Among the strengths of the study, we should men-
t i o nt h ei n c l u s i o no far e p r e s e n t a t i v es a m p l ef r o mt h e
city of Salamanca, as well the proposal to incorporate
functional evaluation and the clinical processes influen-
c i n gt h ep r e v a l e n c eo fC I[ 5 ] .T h es t u d yc o h o r tw o u l d
permit a longitudinal evaluation of CIND, and the long-
term results may contribute to identifying the character-
istics of those individuals who develop dementia.
Conclusions
The observed raw prevalence of CI was 19% (14.9% after
adjusting for age and sex), and corresponds to the lower
range of the prevalence estimated at both national and
international level. Older age and the presence of dia-
betes and anxiety-depression increased the risk of CI,
while higher educational level reduced the risk.
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